Advertisement

Akne, akneiforme Dermatosen und Rosazea

  • Constantin E. Orfanos
  • Claus Garbe

Zusammenfassung

Die Akne ist eine weltweit und in allen Rassen verbreitete Erkrankung. Die klinische Akne hat ihren Gipfel zwischen dem 16. und 18. Lebensjahr und kann in einigen Fällen bis zur 4.–6. Lebensdekade dauern (Spättypakne). Im allgemeinen setzt die Akne bei Mädchen etwas eher ein als bei Jungen. Die Komedonenakne kommt am häufigsten um das 12. Lebensjahr (> 50%) vor, die papulöse und pustulöse Akne um das 16. Lebensjahr mit gut 70–80%, während die tiefen entzündlichen, z. T. knotigen Formen später, zwischen dem 16. und 20. Lebensjahr (ca. 12%) auftreten. Die unterschiedliche Altersverteilung und das differierende klinische Bild der Akne verlangt genaueres Wissen über die Pathogenese der Erkrankung und klinische Erfahrung bei ihrer Behandlung. Akneiforrne Detniatosen oder Medikamente, die akneifotine Hautreaktionen nach sich ziehen, komplizieren das Bild.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aizawa H, Niimura M (1992) Oral spironolactone therapy in male patients with rosacea. J Dermatol 19: 293–297PubMedGoogle Scholar
  2. Akamatsu H, Komura J, Asada Y et al. (1991) Inhibilitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated disease. Arch Dermatol Res 283: 162–166PubMedCrossRefGoogle Scholar
  3. Akamatsu H, Nishijima S, Takahashi M et al. (1991) Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin and minocycline on the chemotactic factor production in Propionibacterium acnes biotype 1–5 for human neutrophils. J Dermatol 18: 247–251PubMedGoogle Scholar
  4. Akamatsu H, Zouboulis ChC, Orfanos CE (1992) Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol 99: 509–511PubMedCrossRefGoogle Scholar
  5. Barth JH, MacDonald-Hull SP, Mark J et al. (1993) Isotretinoin therapy for acne vulgaris: a reevaluation of the needs for measurements of plasmalipids and liver function tests. Br J Dermatol 129: 704–707PubMedCrossRefGoogle Scholar
  6. Chivot M, Midoun H (1990) Isotretinoin and acne–a study of relapses. Dermatologica 180: 240–243PubMedCrossRefGoogle Scholar
  7. Cunliffe WJ (1987) Evolution of a strategy for the treat- ment of acne. J Am Acad Dermatol 16: 591–599PubMedCrossRefGoogle Scholar
  8. Detmar M, Mayer-da Silva A, Stadler R et al. (1989) Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 93: 70–74PubMedCrossRefGoogle Scholar
  9. Downing DT, Stewart ME, Wertz PW et al. (1986) Essential fatty acids and acne. J Am Acad Dermatol 14: 221–225PubMedCrossRefGoogle Scholar
  10. Driesch P von den, Schell H, Haneke E (1986) Acne fulminans: Therapie mit 13-cis-Retinsäure and Indometazin. Z Hautkr 61: 1145–1151PubMedGoogle Scholar
  11. Eady EA, Cove JH, Blake J et al. (1988) Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 118: 415–423Google Scholar
  12. Flückiger R, Furrer HJ, Rufli T (1988) Efficacy and tolerance of a miconazole-benzoyl peroxide cream combination versus a benzoyl peroxide gel in the topical treatment of acne vulgaris. Dermatologica 177: 109–114PubMedCrossRefGoogle Scholar
  13. Fulton JE, Pray SR, Fulton III. JE (1984) Comedogenicity of current therapeutic products cosmetics and ingredients in the rabbit ear. J Am Acad Dermatol 10: 96–105PubMedCrossRefGoogle Scholar
  14. Gassmüller H, Graupe K, Orfanos CE (1985) Azelaic acid and sebum excretion rate. Br J Dermatol 113: 800–802CrossRefGoogle Scholar
  15. Gollnick H (1987) New indications and new retinoids. Dermatologica 175: 192–195CrossRefGoogle Scholar
  16. Gollnick H (1990) A new therapeutic agent: Azelaic acid in acne treatment. J Dermatol Treat 1 [Supp13]: 23–28CrossRefGoogle Scholar
  17. Gollnick H, Graupe K (1989) Azelaic acid for the treatment of acne: Comparative trials. J Dermatol Treat 1: 27–30CrossRefGoogle Scholar
  18. Gollnick HPM, Zouboulis CC, Akamatsu H et al. (1991) Pathogenesis and pathogenesis related treatment of acne. J Dermatol 18: 489–499PubMedGoogle Scholar
  19. Gollnick HPM, Vogt K, Hermann J et al. (1994) Topical chinolone OPC-7251: a clinical and microbiological study. Eur J Dermatol 4: 210–215Google Scholar
  20. Goodfellow A, Alaghband-Zadeh J, Carter G et al. (1984) Oral spironolactone improves acne vulgaris and reduces sebum excretion. Brit J Dermatol 111: 209–214CrossRefGoogle Scholar
  21. Greenwood R, Burke B, Cunliffe WJ (1986) Evaluation of a therapeutic strategy for the treatment of acne vulgaris with conventional therapy. Brit J Dermatol 114: 353–358CrossRefGoogle Scholar
  22. Gudmundsen KJ, O’Donell BF, Powell FC (1992) Schirmer testing in patients with rosacea. J Am Acad Dermatol 26: 211–214PubMedCrossRefGoogle Scholar
  23. Habbema L, Koopmans B, Menke HE et al. (1989) A 4% erythromycin and zinc combination (Zineryt®) versus 2% erythromycin (Eryderm) in acne vulgaris: A randomized double-blind comparative study. Br J Dermatol 121: 497–502PubMedCrossRefGoogle Scholar
  24. Hogan DJ, To T, Wilson ER et al. (1991) A study of acne treatments as risk factors for skin cancer of the head and neck. Br J Dermatol 125: 343–348PubMedCrossRefGoogle Scholar
  25. Holland KT, Bojar RA, Cunliffe WJ et al. (1992) The effect of zinc and erythromycin on the growth of erythromycin-resistant and erythromycin-sensitive isolates of Propionibacterium acnes: an in vitro study. Br J Dermatol 126: 505–509PubMedCrossRefGoogle Scholar
  26. Hughes BR, Murphy CE, Barnett J, Cunliffe WJ (1989) Strategy of acne therapy with long-term antibiotics. Br J Dermatol 121: 623–628PubMedCrossRefGoogle Scholar
  27. Katsambas A, Graupe K, Stratigos J (1989) Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol 143: 35–39Google Scholar
  28. Katsambas A, Towarky AA, Stratigos J (1987) Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris. Br J Dermatol 116: 387–391PubMedCrossRefGoogle Scholar
  29. Layton AM, Knaggs H, Taylor J, Cunliffe WJ (1993) Isotretinoin for acne vulgaris–10 years later: a safe and successful treatment. Br J Dermatol 129: 292–296PubMedCrossRefGoogle Scholar
  30. Lehucher-Cheyrac D, Weber-Buisset MJ (1993) Isotretinoin and acne in practice: a prospective analysis of 188 cases over 9 years. Dermatology 186: 123–128CrossRefGoogle Scholar
  31. Leming JP, Holland KT, Cunliffe WJ (1985) The pathological and ecological significance of microorganisms colonising acne vulgaris comedones. J Med Microbio 120: 11–16CrossRefGoogle Scholar
  32. Lesnik RH, Kligman LH, Kligman AM (1992) Agents that cause enlargement of sebaceous glands in hairless mice. I. Topical substances. Arch Dermatol 284: 100–105CrossRefGoogle Scholar
  33. Lesnik RH, Kligman LH, Kligman AM (1992) Agents that cause enlargement of sebaceous glands in hairless mice. II. Ultraviolet radiation. Arch Dermatol 284: 106–108CrossRefGoogle Scholar
  34. Leyden JJ, McGinley KJ, Foglia AN (1986) Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 86: 390–393PubMedCrossRefGoogle Scholar
  35. Leyden JJ, Shalita AR (1986) Rational therapy for acne vulgaris: An update on tropical treatment. J Am Acad Dermatol 15: 907–914Google Scholar
  36. Mardsen JR, Shuster S (1989) The treatment of acne. In: Greaves MW; Shuster S (eds) Pharmacology of the skin II. Springer, Berlin Heidelberg New York, pp 473Google Scholar
  37. Mayer-da-Silva A, Gollnick H, Detmar M et al. (1989) Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin. An in vivo and in vitro study. Acta Derm Venereol 143: 20–30Google Scholar
  38. Mayer-da-Silva A (1989) Acelaic acid: pharmacology, toxicology and mechanism of action in acne. J Dermatol Treatm 1: 11–16CrossRefGoogle Scholar
  39. Mayer-da-Silva A, Gollnick H, Imcke E et al. (1987) Azelaic acid vs placebo: effects on normal human keratinocytes and melanocytes. Acta Derm Venereol 67: 116–122PubMedGoogle Scholar
  40. Medansky R (1982) Self-evaluation of acne and emotion: a pilot study. Psychosomatics 22: 379–383Google Scholar
  41. Meffert H, Gaunitz K, Gutewort T et al. (1990) Aknetherapie mit sichtbarem Licht. Verkürzung der Bestrahlungszeit durch Verwendung eines Hochdruckstrahlers vom Blaulichttyp. Dermatol Monatsschr 176: 597–603Google Scholar
  42. Mesquita-Guimares J, Ramos S, Tavares MR et al. (1989) A double-blind clinical trial with a lotion containing 5% benzoylperoxyde and 2% miconazole in patients with acne vulgaris. Clin Exp Dermatol 14: 357–360CrossRefGoogle Scholar
  43. Motley RJ, Finlay YY (1989) How much disability is caused by acne? Clin Exp Dermatol 14: 194–198PubMedCrossRefGoogle Scholar
  44. Nacht S, Yeung D, Beasley JN et al. (1981) Benzoyl peroxyde: percutaneous penetration and metabolic disposition. J Am Acad Dermatol 4: 31–34PubMedCrossRefGoogle Scholar
  45. Nader S, Rodriguez-Rigau LJ, Smith KD, Steinberger E (1984) Acne and hyperandrogenism: impact of lowering androgen levels with glucocorticoid treatment. J Am Acad Dermatol 11: 256–259PubMedCrossRefGoogle Scholar
  46. Nazarro-Porro M, Passi S, Picardo M et al. (1983) Benefical effect of 15% azelaic acid creme on acne vulgaris. Br J Dermatol 109: 45–48CrossRefGoogle Scholar
  47. Orfanos CE (1989) Retinoide: der neue Stand. Erhaltungstherapie, Resorptionsstörungen bei „non-responders“, Interaktionen und Interferenzen mit Medikamenten, Behandlung von Kindern und Knochentoxizität, Acitretin und 13-cis-Acitretin. Hautarzt 40: 123–129PubMedGoogle Scholar
  48. Orfanos CE, Ehlert R, Gollnick H (1987) The retinoids–a review of their clinical pharmacology and therapeutic use. Drugs 34: 459–403PubMedCrossRefGoogle Scholar
  49. Pierini AM, Gutierrez O, Scrigni A, Ordonez CP (1993) Acne fulminans. A proposito de un caso con pericarditis. Arch Argent Dermatol XLIII: 315–323Google Scholar
  50. Pochi PE (1988) Endocrine therapy of acne. In: Orfanos CE, Stadler R, Gollnick H (eds) Dermatology in five continents. Proc 17th World Cong Dermatol. Springer, Berlin Heidelberg New York pp 401–106Google Scholar
  51. Pochi PE (1990) The pathogenesis and treatment of acne. Ann Rev Med 41: 181–198CrossRefGoogle Scholar
  52. Pochi PE, Shalita AR, Strauss JS et al. (1991) Report of the consensus conference on acne classification. J Am Acad Dermatol 24: 495–500PubMedCrossRefGoogle Scholar
  53. Pochi PE, Strauss JS, Downing DT (1979) Age related changes in sebaceous gland activity. J Invest Dermatol 73: 108–111PubMedCrossRefGoogle Scholar
  54. Rajka G (1985) On therapeutic approaches to some special types of acne. Acta Derm Venereol 120: 39–42Google Scholar
  55. Roenigk HH, Pinski JB, Robinson JK, Hanke CW (1985) Akne retinoids and dermabrasion. J Dermatol Surg Oncol 11: 396–398PubMedGoogle Scholar
  56. Rubenstein R, Roenigk HH Jr, Stegman SJ, Hanke CW (1986) Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol 15: 280–285PubMedCrossRefGoogle Scholar
  57. Rumsfield JA, West DP, Tse CS et al. (1983) Isotretinoin in severe, recalcitrant cystic acne: a review. Drug Intell Clin Pharm 17: 329–333PubMedGoogle Scholar
  58. Schachner L, Eaglstein W, Kitties C et al. (1990) Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol 22: 253–260PubMedCrossRefGoogle Scholar
  59. Schell H (1985) Formenkreis der Akne und Rosacea. In: Hornstein OP, Nürnberg E (eds) Externe Therapie von Hautkrankheiten. Thieme, Stuttgart New York, pp 352–361Google Scholar
  60. Schmidt JB, Spona J (1983) Haut-Wirkungen von Östriol–Klinische, hormonelle und Sebum-Parameter bei Patientinnen mit Akne. Z Hautkr 58: 1228–1241PubMedGoogle Scholar
  61. Schmidt JB, Gebhardt W, Raff M, Spona J (1984) 13-cis retinoic acid in rosacea. Acta Derm Venereol 64: 15–21Google Scholar
  62. Schmidt JB, Neumann R, Fanta D, Raab W (1988) 1% Clindamycinphosphatlösung versus 5% Benzoylperoxyd-Gel bei papulopustulöser Akne. Z Hautkr 63: 374–376Google Scholar
  63. Schutte H, Cunliffe WJ, Forster RA (1982) The short-term effects of benzoylperoxyde lotion on the resolution of inflamed acne lesions. Brit J Dermatol 106: 91–94CrossRefGoogle Scholar
  64. Slaga TJ, Klein-Szanto AJP, Triplett LL et al. (1981) Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating component. Science 213: 1023–1025PubMedCrossRefGoogle Scholar
  65. Stainforth JM, Layton AM, Taylor JP, Cunliffe WJ (1993) Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol 129: 297–301PubMedCrossRefGoogle Scholar
  66. Stern RS, Pass TM, Komaroff AL (1984) Topical and systemic agent treatment for papulopustular acne. A cost-effectiveness analysis. Arch Dermatol 120: 1571–1578Google Scholar
  67. Studt H, Riehl A, Gollnick H (1986) Acne conglobata: Persönlichkeit und seelische Folgen einer 13-cisRetinsäure-Therapie. Z Hautkr 61: 743–754PubMedGoogle Scholar
  68. Täuber U, Weiss C, Matthes H (1992) Percutaneous absorption of acelaic acid in humans. Exp Dermatol 1: 176–179PubMedCrossRefGoogle Scholar
  69. Tipper JL, Jones CE, Cove JH et al. (1992) The continuing evolution of antibiotic resistant Propionibacteria: an emerging clinical problem. J Invest Dermatol 98: 521Google Scholar
  70. Traupe H, von Muhlendahl KE, Bramswig J, Happle R (1988) Acne of the fulminans type following testosterone therapy in three excessively tall boys. Arch Dermatol 124: 414–417PubMedCrossRefGoogle Scholar
  71. Tunessen WW (1984) Acne: An approach to therapy for the pediatrician. Adv Pediatr 31: 325–358Google Scholar
  72. Verschoore M, Langner A, Wolska H et al. (1991) Efficacy and safety of CD271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol 124: 368–371PubMedCrossRefGoogle Scholar
  73. Verschoore M, Schäfer H (1991) Topische Retinoide und Akne. Z Hautkr 66: 36–38Google Scholar
  74. Vogt K, Hermann J, Blume U et al. (1992) Comparative activity of the topical chinolone OPC-7251, a new chinolone in acne vulgaris. Eur J Clin Microbiol Infect Dis 11 /10: 943–945PubMedCrossRefGoogle Scholar
  75. Yonkonsky DM, Pochi PE (1986) Acne vulgaris in childhood. Pathogenesis and management. Pediatr Dermatol 4: 127–136Google Scholar
  76. Zina G, Colonna S (1989) The long-term treatment of acne with azelaic cream. J Dermatol Treat 1: 21–26CrossRefGoogle Scholar
  77. Zouboulis CC, Gollnick H (1991) The difficult cases: Cryosurgical treatment of keloids and hypertrophie scars. In: Panconesi E (ed) Dermatology in Europe. Proc 1st Cong Eur Acad Dermatol Venerol. Blackwell, Oxford, pp 417–419Google Scholar
  78. Zouboulis CC, Korge B, Akamatsu H et al. (1991) Effects of 13-cis-retinoic acid, all-trans-retinoic acid and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol 96: 792–797(s. S. 789 f.) vor und nach dem Peeling zur täglichen Anwendung verordnet werden.Google Scholar
  79. Beeson WH, McColough EG (1985) Chemical face peeling without taping. J Dermatol Surg Oncol 11: 985–990PubMedGoogle Scholar
  80. Benedetto AV, Griffin TD, Benedetto EA, Humeniuk HM (1992) Dermabrasion: Therapy and prophylaxis of the photoaged skin. J Am Acad Dermatol 27: 439–447PubMedCrossRefGoogle Scholar
  81. Brody HJ (1991) The role of chemical peeling in the treatment of photodamaged skin. J Dermatol Surg Oncol 16: 945–954Google Scholar
  82. Coleman WP (1991) Surgical notes. Dermabrasion and hypertrophic scars. Int J Dermatol 30: 629–631PubMedCrossRefGoogle Scholar
  83. Don PC Carney PS, Lynch WS (1987) Carbon dioxide laser abrasion: a new approach to management of familial benign chronic pemphigus ( Hailey-Hailey disease ). J Dermatol Surg Oncol 13: 1187–1194Google Scholar
  84. Drake DB, Morgan RF, Cooper PH (1992) Shave excision and dermabrasion for facial angiofibroma in tuberous sclerosis. Ann Plast Surg 28: 377–380PubMedCrossRefGoogle Scholar
  85. Fratila A, Uerlich M (1992) Chemical peeling. Z Hautkr 67: 639–647Google Scholar
  86. Fulton JE (1991) The prevention and management of postdermabrasion complications: J Dermatol Surg Oncol 17: 431–437PubMedGoogle Scholar
  87. Katz BE, Oca AG (1991) A controlled study of the effectiveness of spot dermabrasion („scarabrasion“) on the appearance of surgical scars. J Am Acad Dermatol 24: 462–466PubMedCrossRefGoogle Scholar
  88. Matarasso SL, Salman SM, Glogau RG, Rogers GS (1990) The role of chemical peeling in the treatment of photodamaged skin. J Dermatol Surg Oncol 16: 945–954PubMedGoogle Scholar
  89. McCollough EG, Langsdon PR (1988) (eds) Dermabrasion and chemical peel. A guide for facial plastich surgeons. Thieme, Stuttgart New YorkGoogle Scholar
  90. Melandri A, Carruthers A (1992) Widespread basal carcinoma of the scalp treated by dermabrasion. J Am Acad Dermatol 26: 270–271PubMedCrossRefGoogle Scholar
  91. Monheit GD (1989) The Jessner’s TCA peel: a medium-depth chemical peel. J Dermatol Surg Oncol 15: 945–950PubMedGoogle Scholar
  92. Morrow M (1992) Chemical peeling of eyelids and periorbital area. J Dermatol Surg Oncol 18: 102–110 Peters W (1991) The chemical peel. Ann Plast Surg 26: 564–571Google Scholar
  93. Raab B (1991) A new hydrophilic copolymer membrane for dermabrasion. J Dermatol Surg Oncol 17: 323–328PubMedGoogle Scholar
  94. Shiarello SE (1992) Full face cryo-(liquid nitrogen) peel. J Dermatol Surg Oncol 18: 329–332Google Scholar
  95. Spencer JM, Katz BE (1992) Successful treatment of porokeratosis of Mibelli with diamond fraise dermabrasion. Arch Dermatol 128: 1187–1189PubMedCrossRefGoogle Scholar
  96. Zachariae B (1992) Dermabrasion of Hailey-Hailey disease and Darier’s disease. J Am Acad Dermatol 27: 136PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • Constantin E. Orfanos
    • 1
  • Claus Garbe
    • 1
  1. 1.Universitäts-Hautklinik und PoliklinikKlinikum Benjamin Franklin der Freien Universität BerlinBerlinDeutschland

Personalised recommendations